Warning: The NCBI web site requires JavaScript to function. more...
Tumour necrosis factor blockade and the risk of osteoporosis: back to the future.
Sambrook P.
Arthritis Res Ther. 2007;9(4):107.
Related citations
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.
Ann Rheum Dis. 2009 Mar;68(3):373-6. Epub 2008 Apr 13.
Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.
J Rheumatol. 1997 Aug;24(8):1489-94.
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U, Teichmann J, Müller-Ladner U, Strunk J.
Rheumatology (Oxford). 2005 Dec;44(12):1546-8. Epub 2005 Nov 1.
The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.
Hämäläinen H, Kautiainen H, Kaarela K, Kotaniemi A.
Clin Exp Rheumatol. 2005 Mar-Apr;23(2):193-8.
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
Ann Rheum Dis. 2008 Jun;67(6):823-8. Epub 2007 Jul 20.
Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.
Barnabe C, Hanley DA.
Semin Arthritis Rheum. 2009 Oct;39(2):116-22. Epub 2008 Jun 30. Review.
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.
Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallée C, de Bois MH, Breedveld FC, Dijkmans BA, Lems WF.
Ann Rheum Dis. 2009 Mar;68(3):330-6. Epub 2008 Mar 28.
Preferential reduction of bone mineral density at the femur reflects impairment of physical activity in patients with low-activity rheumatoid arthritis.
Sugiguchi S, Goto H, Inaba M, Nishizawa Y.
Mod Rheumatol. 2010 Feb;20(1):69-73.
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
Ann Rheum Dis. 2008 Mar;67(3):353-7. Epub 2007 Jul 20.
Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C, Karlsson M, Akesson K, Jacobsson L.
Scand J Rheumatol. 2008 Jul-Aug;37(4):248-54.
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.
Marotte H, Pallot-Prades B, Grange L, Gaudin P, Alexandre C, Miossec P.
Arthritis Res Ther. 2007;9(3):R61.
Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
Mazzantini M, Di Munno O, Sinigaglia L, Bianchi G, Rossini M, Mela Q, Del Puente A, Frediani B, Cantatore F, Adami S.
Clin Exp Rheumatol. 2007 Sep-Oct;25(5):709-15.
Determinants of axial bone loss in rheumatoid arthritis.
Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S.
Arthritis Rheum. 1987 Jul;30(7):721-8.
Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
Hämäläinen H, Kaarela K, Kröger H, Kauppi M, Järvenpää S, Hakala M, Kotaniemi A.
Joint Bone Spine. 2007 Oct;74(5):482-7. Epub 2007 May 30.
Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.
Martyn-St James M, Carroll S.
Bone. 2008 Sep;43(3):521-31. Epub 2008 May 26.
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Wang SX, Li H.
Chin Med J (Engl). 2008 Jul 20;121(14):1280-4.
Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
Frediani B, Falsetti P, Bisogno S, Baldi F, Acciai C, Filippou G, Bacarelli MR, Filipponi P, Galeazzi M, Marcolongo R.
J Rheumatol. 2004 Jun;31(6):1083-7.
Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital.
Nolla JM, Roig-Vilaseca D, Gomez-Vaquero C, Mateo L, Juanola X, Rodriguez-Moreno J, Narvaez J, Valverde J.
J Rheumatol. 2006 Aug;33(8):1472-5.
Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH.
J Clin Rheumatol. 2009 Jun;15(4):155-60.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on